Clinical Trials

Study Title:
A Phase 3 Randomized Non Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727, IND# 77782) in Newly Diagnosed or Previously Untreated Low Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)

For more information about the trial above please contact the study team:

Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.

Study Coordinator, Sarah Milligan, at millisar@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina